The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

Thanks to America's fixation with eating more protein, the market for protein bars has expanded. Because of this, protein bar ...

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...

The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...

The article covers Daylight Saving Time's history, health impact, remedies like light therapy, sleep hygiene, gradual ...

The legislative session begins Feb. 4. Here are four key issues that will likely come up and four that likely won’t. Alabama ...